• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明胶酶A(MMP-2)对前明胶酶B(MMP-9)的激活作用。

Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).

作者信息

Fridman R, Toth M, Peña D, Mobashery S

机构信息

Department of Pathology, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

Cancer Res. 1995 Jun 15;55(12):2548-55.

PMID:7780967
Abstract

The M(r) 72,000 (MMP-2; gelatinase A) and M(r) 92,000 (MMP-9; gelatinase B) gelatinases are two members of the family of matrix metalloproteinases (MMPs). These proteinases are thought to play a critical role in tumor cell invasion and are frequently coexpressed in human cancers. Gelatinases are secreted in a latent inactive form, and their conversion to the active species can be accomplished by other proteolytic enzymes, including other MMPs. We report herein that organomercurial or plasma membrane-activated M(r) 72,000 gelatinase A activates progelatinase B to an M(r) 82,000 active form in a process inhibited by tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. Progelatinase B activation was accomplished by the two active species of gelatinase A, the M(r) 62,000 and M(r) 45,000 forms, generated after plasma membrane or organomercurial activation of TIMP-2-free progelatinase A. The M(r) 45,000 species of gelatinase A lacks both the NH2-terminal profragment and the COOH-terminal domain known to play a role in plasma membrane activation and the regulation of TIMP-2 inhibition. These results suggest a novel mechanism of activation of progelatinase B mediated by gelatinase A species that may be localized in the surface of tumor cells and enhance matrix degradation during cancer metastasis.

摘要

分子量为72,000(基质金属蛋白酶-2;明胶酶A)和分子量为92,000(基质金属蛋白酶-9;明胶酶B)的明胶酶是基质金属蛋白酶(MMPs)家族的两个成员。这些蛋白酶被认为在肿瘤细胞侵袭中起关键作用,且在人类癌症中经常共同表达。明胶酶以潜在的无活性形式分泌,它们向活性形式的转化可由其他蛋白水解酶完成,包括其他基质金属蛋白酶。我们在此报告,有机汞或质膜激活的分子量为72,000的明胶酶A在金属蛋白酶组织抑制剂(TIMP)-1和TIMP-2抑制的过程中将前明胶酶B激活为分子量为82,000的活性形式。前明胶酶B的激活是由明胶酶A的两种活性形式完成的,即无TIMP-2的前明胶酶A经质膜或有机汞激活后产生的分子量为62,000和分子量为45,000的形式。分子量为45,000的明胶酶A既缺乏已知在质膜激活和TIMP-2抑制调节中起作用的NH2末端前肽段,也缺乏COOH末端结构域。这些结果提示了一种由可能定位于肿瘤细胞表面的明胶酶A介导的前明胶酶B激活的新机制,该机制可能在癌症转移过程中增强基质降解。

相似文献

1
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).明胶酶A(MMP-2)对前明胶酶B(MMP-9)的激活作用。
Cancer Res. 1995 Jun 15;55(12):2548-55.
2
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.金属蛋白酶组织抑制剂-4通过有效抑制膜型1-基质金属蛋白酶来抑制而非支持明胶酶A的激活。
Cancer Res. 2001 May 1;61(9):3610-8.
3
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).金属蛋白酶组织抑制剂2(TIMP-2)的序列基序决定了前明胶酶A(proMMP-2)与膜型金属蛋白酶1(MT1-MMP)的结合及激活。
Biochem J. 2003 Jun 15;372(Pt 3):799-809. doi: 10.1042/BJ20021573.
4
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.膜型基质金属蛋白酶在人恶性脑肿瘤体内外的差异表达及其与明胶酶A激活的相关性
Cancer Res. 1996 Jan 15;56(2):384-92.
5
Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.佛波酯对人脐静脉内皮细胞前明胶酶A的激活作用:一种涉及膜型基质金属蛋白酶的蛋白激酶C依赖性机制
Lab Invest. 1996 Feb;74(2):538-45.
6
Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.重组膜型1基质金属蛋白酶对72千道尔顿IV型胶原酶/明胶酶A前体的加工处理
Cancer Res. 1996 Jun 1;56(11):2535-8.
7
Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.细胞侵袭中的膜型基质金属蛋白酶(MT - MMPs)
Thromb Haemost. 1997 Jul;78(1):497-500.
8
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.基质金属蛋白酶-2和-9在人神经母细胞瘤中表达:基质细胞对其产生的作用及其与转移的相关性
Cancer Res. 1998 May 15;58(10):2209-16.
9
Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.前胶原酶A由大鼠肝星状细胞产生并激活,促进其增殖。
Hepatology. 1999 Oct;30(4):977-86. doi: 10.1002/hep.510300431.
10
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.膜型基质金属蛋白酶1是一种明胶分解酶,它与金属蛋白酶组织抑制剂2形成复合物后分泌。
Cancer Res. 1996 Jun 15;56(12):2707-10.

引用本文的文献

1
The Diverse Pathways for Cell Surface MT1-MMP Localization in Migratory Cells.迁移细胞中细胞表面MT1-MMP定位的多种途径。
Cells. 2025 Jan 31;14(3):209. doi: 10.3390/cells14030209.
2
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators.血浆基质金属蛋白酶 9 的调节:一种用于理解囊性纤维化跨膜电导调节剂调节剂治疗囊性纤维化患者临床反应差异的有前途的新工具。
Int J Mol Sci. 2023 Aug 29;24(17):13384. doi: 10.3390/ijms241713384.
3
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss.
新型多效基质金属蛋白酶抑制剂CMC2.24在严重高血糖诱导的长期糖尿病大鼠口腔骨质流失模型中的疗效
J Inflamm Res. 2023 Feb 23;16:779-792. doi: 10.2147/JIR.S399043. eCollection 2023.
4
Matrix metalloproteinase profiling and their roles in disease.基质金属蛋白酶分析及其在疾病中的作用。
RSC Adv. 2023 Feb 21;13(9):6304-6316. doi: 10.1039/d2ra07005g. eCollection 2023 Feb 14.
5
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.脑脊液中基质金属蛋白酶与组织型抑制剂比率降低与散发型和遗传性脑淀粉样血管病有关。
Alzheimers Res Ther. 2023 Jan 30;15(1):26. doi: 10.1186/s13195-023-01171-3.
6
Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy.通过壳聚糖包被的硒纳米颗粒抑制脑癌转移并提高化疗敏感性用于脑癌治疗
Nanomaterials (Basel). 2022 Jul 29;12(15):2606. doi: 10.3390/nano12152606.
7
Gain of function of a metalloproteinase associated with multiple myeloma, bicuspid aortic valve, and Von Hippel-Lindau syndrome.与多发性骨髓瘤、二叶式主动脉瓣和 Von Hippel-Lindau 综合征相关的金属蛋白酶功能获得。
Biochem J. 2022 Jul 29;479(14):1533-1542. doi: 10.1042/BCJ20220166.
8
Infarct in the Heart: What's MMP-9 Got to Do with It?心肌梗死:MMP-9 在其中扮演什么角色?
Biomolecules. 2021 Mar 25;11(4):491. doi: 10.3390/biom11040491.
9
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin.以积雪草苷和柚皮素靶向转化生长因子-β-信号转导分子Smad-基质金属蛋白酶2通路抑制肿瘤侵袭和转移
Mol Ther Oncolytics. 2021 Jan 20;20:277-289. doi: 10.1016/j.omto.2021.01.006. eCollection 2021 Mar 26.
10
Induction of synthesis of matrix metalloproteinases by interleukin-6; evidence for hepatic regeneration following hemi-hepatectomy.白细胞介素-6诱导基质金属蛋白酶的合成;半肝切除术后肝再生的证据。
Clin Exp Hepatol. 2020 Jun;6(2):137-141. doi: 10.5114/ceh.2020.95679. Epub 2020 May 27.